Document is current

Article History

Received: 23 July 2025

Accepted: 18 November 2025

First Online: 26 November 2025

Declarations

:

: The study protocol was reviewed and approved by the Joint Chinese University of Hong Kong-New Territories East Cluster Clinical Research Ethics Committee (Ref. No.: 2024.702-T). It has also been registered at the Chinese Clinical Trial Registry (Version: 1.0; Date: August 27, 2025; Identifier: ChiCTR2500108295). The study adheres to the ethical guidelines of the Joint CUHK-NTEC CREC Institutional Review Board/Research Ethics Committee Standard Operating Procedures (IRB/REC SOP), the Declaration of Helsinki and the International Council for Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use Guidelines for Good Clinical Practice (ICH-GCP). Any major changes to the research protocol must be approved again by the ethics committee before implementation.During the implementation, the Joint Chinese University of Hong Kong-New Territories East Cluster Clinical Research Ethics Committee will supervise this study. This study does not establish a formal Data Monitoring Committee (DMC) due to the low-risk nature of educational intervention. Instead, internal monitoring procedures are implemented by the research team, including weekly teacher workshops, session logs, and fidelity checklists to ensure adherence to the intervention protocol. No interim analyses or formal stopping guidelines are planned. The study will proceed as scheduled unless serious adverse events or implementation challenges arise, in which case the principal investigator and research team will make decisions regarding continuation or modification.

: Not applicable.

: The authors declare no competing interests.